Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PCDH9 antisense RNA 2 (PCDH9-AS2) is a long non-coding antisense RNA gene located on chromosome 13, transcribed in the opposite direction to the protein-coding PCDH9 gene[2][4][6][7]. It does not encode a protein. Instead, it is predicted to regulate PCDH9 expression through cis-regulatory mechanisms, which may in turn influence the biological functions of the PCDH9 protein in cell-cell adhesion, formation of cell junctions, and neuronal connectivity[2]. Despite these predicted roles, the exact biological functions of PCDH9-AS2, and any direct involvement in disease, remain to be fully elucidated[2]. There are currently no reported drugs that target PCDH9-AS2, and it is not considered a canonical therapeutic target (such as a receptor, enzyme, or transporter)[2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PCDH9 antisense RNA 2 (non-protein coding) (PCDH9-AS2).